Baltimore commemorates 200th birthday of Edgar Allan Poe
Charm City is throwing a city-wide celebration in honor of the famed writer with special events planned throughout the year. Highlights of “Nevermore 2009” include:
• Baltimore City’s Edgar Allan Poe Bicentennial Birthday Celebration (January 17, 18, 31, and February 1)
• “Edgar Allan Poe: More Than a Poet” exhibition at Enoch Pratt Free Library (starts January 19)
• The Fall of the House of Usher at Black Box Theatre (February 27 – 28)
• “Cask of Amontillado Wine Tasting Among the Bones” (March 27)
• Public viewing on the anniversary of his death (October 9)
• Re-enactment of his funeral service (October 10)
• “Art of Darkness” exhibition at Baltimore Museum of Art (October – December)
In addition to these happenings, along with special tours and lectures, you can also visit the Edgar Allan Poe House and Museum in West Baltimore, as well as his gravesite at Westminster Hall Burying Grounds.
For complete details on events and ticket prices, log on to www.nevermore2009.com.
Source: The Baltimore Area Convention and Visitors Association. (2008, October 30). Quoth the raven: Nevermore 2009 in Baltimore. PR Newswire. Retrieved October 30, 2008, from http://www.prnewswire.com/
MORE ARTICLES IN THIS ISSUE
From tours and new attractions to anniversary celebrations and theatrical productions, Chicago is the place to be in 2009.
A study conducted by researchers at West Virginia University shows that injuries needing hospital care happen more often in rural regions than in urban areas.
Enjoy yourself and help support the arts at the 12th annual ARTfeast Santa Fe, taking place February 20 ? 22. This unique festival brings together first-rate chefs and artists for a variety of events around the city, with proceeds going toward art programs and scholarships for children.
According to a recent international survey, doctors are more desirable as marriage partners than people in any other career field. The poll also showed that medicine is the most trusted and admired profession.
Last month, the FDA approved degarelix for the treatment of advanced prostate cancer. Administered via injection, the new drug is a gonadotropin releasing hormone (GnRH) receptor inhibitor?an agent that hinders development of prostate cancer by curbing testosterone.